JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Submission Of Certificate From Practising Company Secretary Under Reg. 40(9) Of SEBI (LODR) Reg. 2015
We hereby submit a certificate from Practising Company Secretary under Reg. 40(9) of SEBI (LODR) Reg. 2015 for the year ended March 31, 2024. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith details received regarding issue of duplicate share certificate of shareholders from our Registrar and Share Transfer Agent - MCS Share Transfer Agent Limited. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 we are enclosing herewith a copy of the certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended March 31, 2024. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Submission Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Compliance Certificate jointly executed by the authorized representative of our share transfer agent viz. MCS Share Transfer Agent Limited and the Compliance Officer of Jagsonpal Pharmaceuticals Limited for the year ended March 31, 2024. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Closure of Trading Window
In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code of Conduct to regulate, monitor and report trading by designated persons & immediate relatives of Designated persons, the Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited (''''the Company'''') shall remain closed for Designated Persons and their immediate relative(s) with effect from Monday, April 01, 2024 till the end of 48 hours after the declaration of Audited Financial Results for the quarter and Financial year ended March 31, 2024. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Pursuant to SEBI ( Listing Obligations and Disclosure Requirements), 2015, as amended, we are pleased to inform you that the Nomination and Remuneration Committee has issued and allotted 1,00,000 Equity Shares of Rs.5/- each under JPL ESOP 2022, to the eligible employee of the company , upon exercise of vested option. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith a copy of the Press Release issued by the Company titled ''Jagsonpal Pharmaceuticals launches QueeZy-ER. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We wish to inform you that the Company is participating in the ''Systematix Group -Pharma & Healthcare Day' scheduled to be held on Wednesday, March 13, 2024 where the Company will be interacting with the institutional investors at Mumbai. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issuance of Letter of Confirmation in lieu of Duplicate Share Certificate JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith details regarding loss of duplicate share certificate of shareholders from our RTA - MCS Share Transfer Agent Limited.